Moving rumors and bubbling lava
TheState.com - There s a minimum $5 donation, and all proceeds will benefit the Chris Conner Foundation. Ashleigh Pair , the foundation s executive director, told us Conner, who has inoperable lung cancer, is doing well. Conner wrote in a recent caringbridge.org
Biomoda files another patent on porphyrin molecule
MSN MoneyCentral - Biomoda Inc. has filed another patent application to protect use of its already-patented porphyrin molecule. Albuquerque-based Biomoda, which is developing early lung cancer detection and diagnostics technologies, filed for patent protection in mid
Vitamin D may fight cancers
Buffalo News - The institute also recently started a clinical trial of high-dose vitamin D replacement in individuals with high risk of lung cancer, and other scientists there are looking at boosting the effect of chemotherapy by adding vitamin D. The evidence
NHS to pay for 163 drug to help smokers quit
Daily Telegraph - Anti-cancer drugs that have been rejected by Nice include Avastin and Erbitux for bowel cancer, Tarceva for non-small cell lung cancer, Velcade for bone marrow cancer, and Alimta for mesothelioma, a cancer caused by exposure to asbestos. Dr Eamonn
Times Writers Group: Smoking ban comes at high cost
St. Cloud Times - Paul Legal Ledger, noted scientific studies that show a nonsmoker working full-time in a smoking environment for 21 years faces a 25 percent increased risk of lung cancer. Trojan horse Meantime, I can mine coal even though mining is unsafe, but I can’t
OPENING ACT
Citizen’s Voice - is an addictive drug, which when inhaled in cigarette smoke reaches the brain faster than drugs that enter the body intravenously, McGeehan said. During the past few days, a close friend and a colleague were each diagnosed with lung cancer and
Non-Small-Cell Lung Cancer Drug Market in China will Reach $640
PR Newswire - WALTHAM, Mass., May 29 /PRNewswire/ — Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, forecasts that the non-small-cell lung cancer drug market in China will reach $640